Video: Angela Osborne Discusses the Latest Cell and Gene Industry Trends
Check out our video interview with Angela Osborne, CEO and founder of eXmoor Pharma, who joined us from the ISCT convention in Paris (2023).
Stephanie Vine | | Video
With over 30 years’ experience in biopharmaceutical and cell and gene therapy businesses, Angela Osborne shares valuable insight on the latest industry trends, investment strategies in CGT, COVID-19, iPSCs, and more!
Originally a biochemical engineer from UCL, Angela is the CEO and founder of eXmoor pharma, a “trusted one-stop cell and gene therapy partner, accelerating the manufacturing journey from research to patients,” which she founded in 2004.
In the past, Angela was Senior Vice President of Pharmaceuticals at Aker Kvaerner, an engineering multinational, where she grew the turnover to equal the previously dominant chemicals business. Angela started her career at British Biotech, where she built on her PhD, with practical experience of biopharmaceutical process development, scale-up, facility design, validation, and operation of facilities to US and EU GMPs.
Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.
